Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

596 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence.
Ait-Daoud N, Johnson BA, Prihoda TJ, Hargita ID. Ait-Daoud N, et al. Psychopharmacology (Berl). 2001 Feb;154(1):23-7. doi: 10.1007/s002130000607. Psychopharmacology (Berl). 2001. PMID: 11292002 Clinical Trial.
Isradipine, a dihydropyridine-class calcium channel antagonist, attenuates some of d-methamphetamine's positive subjective effects: a preliminary study.
Johnson BA, Roache JD, Bordnick PS, Ait-Daoud N. Johnson BA, et al. Psychopharmacology (Berl). 1999 Jun;144(3):295-300. doi: 10.1007/s002130051007. Psychopharmacology (Berl). 1999. PMID: 10435398 Clinical Trial.
Combining ondansetron and naltrexone treats biological alcoholics: corroboration of self-reported drinking by serum carbohydrate deficient transferrin, a biomarker.
Ait-Daoud N, Johnson BA, Javors M, Roache JD, Zanca NA. Ait-Daoud N, et al. Alcohol Clin Exp Res. 2001 Jun;25(6):847-9. Alcohol Clin Exp Res. 2001. PMID: 11410720 Clinical Trial.
Ondansetron and alcohol pharmacokinetics.
Johnson BA, Rue J, Cowen PJ. Johnson BA, et al. Psychopharmacology (Berl). 1993;112(1):145. doi: 10.1007/BF02247376. Psychopharmacology (Berl). 1993. PMID: 7871005 Clinical Trial. No abstract available.
Ritanserin in the treatment of alcohol dependence--a multi-center clinical trial. Ritanserin Study Group.
Johnson BA, Jasinski DR, Galloway GP, Kranzler H, Weinreib R, Anton RF, Mason BJ, Bohn MJ, Pettinati HM, Rawson R, Clyde C. Johnson BA, et al. Psychopharmacology (Berl). 1996 Nov;128(2):206-15. doi: 10.1007/s002130050126. Psychopharmacology (Berl). 1996. PMID: 8956382 Clinical Trial.
Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial.
Johnson BA, Roache JD, Javors MA, DiClemente CC, Cloninger CR, Prihoda TJ, Bordnick PS, Ait-Daoud N, Hensler J. Johnson BA, et al. JAMA. 2000 Aug 23-30;284(8):963-71. doi: 10.1001/jama.284.8.963. JAMA. 2000. PMID: 10944641 Clinical Trial.
596 results
Jump to page